SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Revenue (TTM)
$166.95M
+1.8% YoY
Q2 Aug 2017
Net Income (TTM)
$43.24M
−36.6% YoY
Q2 Aug 2017
EPS Diluted (TTM)
$0.82
−36.8% YoY
Q2 Aug 2017
Gross Margin
89.9%
Q2 Aug 2017
Operating Margin
25.7%
Q2 Aug 2017
Net Margin
25.9%
Q2 Aug 2017
Free Cash Flow (TTM)
$8.5M
Q2 Aug 2017
Cash
$157.33M
Q2 Aug 2017
Total Debt
$1.61M
Q2 Aug 2017
Shares Outstanding
52.19M sh
Q2 Aug 2017